Kegg medicus dgroup en
| DG01794 | |
| DG number | DG01794 |
| Classification | DGroup |
| Name | SGLT2 inhibitor |
| Stem | -gliflozin TYPE Target, Class |
| Structural formula |  |
| Member | DG00122 Dapagliflozin D08897 Dapagliflozin (USAN/INN) D09763 Dapagliflozin propanediol (USAN); Dapagliflozin propylene glycolate hydrate (JAN) D09592 Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN) D10459 Empagliflozin (JAN/USAN/INN) DG02836 Ertugliflozin D10313 Ertugliflozin (USAN/INN) D11043 Ertugliflozin pidolate DG01248 Ipragliflozin D10196 Ipragliflozin (INN) D10200 Ipragliflozin L-proline (JAN) D10669 Sotagliflozin (USAN/INN) D10195 Luseogliflozin hydrate (JAN) D09978 Tofogliflozin (USAN); Tofogliflozin hydrate (JAN) D06641 Sergliflozin etabonate (USAN) D10055 Remogliflozin etabonate (USAN/INN) D10865 Bexagliflozin (USAN) |
| Upper group | Antidiabetic agent DG02044 Hypoglycemic agent |
| Remark | ATC code: A10BK |
| Comment | - |